Literature DB >> 16616491

RNA interference by 2',5'-linked nucleic acid duplexes in mammalian cells.

Thazha P Prakash1, Bryan Kraynack, Brenda F Baker, Eric E Swayze, Balkrishen Bhat.   

Abstract

Synthetic small interfering RNA (siRNA) mediated silencing of a specific gene is emerging as a powerful tool for gene regulation. However, their utility is limited for therapeutic applications primarily due to poor stability. The 2',5'-linked oligonucleotides are known to be more stable to nucleolytic degradation than 3',5'-linked oligonucleotides. The 2',5'-linkage is tolerated in the sense strand of the siRNA duplex. However, the 2',5'-linkage is not tolerated in the antisense strand of the siRNA duplex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616491     DOI: 10.1016/j.bmcl.2006.03.053

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  Effect of 2'-5'/3'-5' phosphodiester linkage heterogeneity on RNA interference.

Authors:  Maryam Habibian; S Harikrishna; Johans Fakhoury; Maria Barton; Eman A Ageely; Regina Cencic; Hassan H Fakih; Adam Katolik; Mayumi Takahashi; John Rossi; Jerry Pelletier; Keith T Gagnon; P I Pradeepkumar; Masad J Damha
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

2.  Development of Therapeutic-Grade Small Interfering RNAs by Chemical Engineering.

Authors:  Jesper B Bramsen; Jørgen Kjems
Journal:  Front Genet       Date:  2012-08-20       Impact factor: 4.599

Review 3.  RNAi therapeutics: a potential new class of pharmaceutical drugs.

Authors:  David Bumcrot; Muthiah Manoharan; Victor Koteliansky; Dinah W Y Sah
Journal:  Nat Chem Biol       Date:  2006-12       Impact factor: 15.040

Review 4.  Inhaled siRNA Formulations for Respiratory Diseases: From Basic Research to Clinical Application.

Authors:  Yulin Fan; Zhijun Yang
Journal:  Pharmaceutics       Date:  2022-06-02       Impact factor: 6.525

5.  Site-specific Incorporation of 2',5'-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense Oligonucleotides.

Authors:  Thazha P Prakash; Jinghua Yu; Wen Shen; Cheryl Li De Hoyos; Andres Berdeja; Hans Gaus; Xue-Hai Liang; Stanley T Crooke; Punit P Seth
Journal:  ACS Med Chem Lett       Date:  2021-04-05       Impact factor: 4.632

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.